A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats

Journal

• J Pharmacol Exp Ther

  J Pharmacol Exp Ther 314 410-421, 2005